<span itemprop="author">Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO

Author's posts

Why does rifaximin cost 95 percent more in the U.S. than in Asia?

Rifaximin, a minimally absorbed antibiotic, has become a cornerstone therapy for several gastrointestinal disorders, including irritable bowel syndrome with diarrhea (IBS-D) and hepatic encephalopathy. Despite its established use, access to rifaximin v…